Research

Learn about the latest research for new treatments, prevention, and a cure for type 1 diabetes.

Insulet Begins Pivotal Study of Fully Closed-Loop Omnipod for Type 2

News

May 4, 2026

Insulet Begins Pivotal Study of Fully Closed-Loop Omnipod for Type 2

Insulet has enrolled its first participant in its EVOLVE trial testing an automated system designed to eliminate mealtime bolus announcements for people with type 2 diabetes.

FDA Expands Tzield to Children Age 1+ to Delay Type 1 Diabetes

News

Apr 28, 2026

FDA Expands Tzield to Children Age 1+ to Delay Type 1 Diabetes

Sanofi's disease-modifying therapy can now be used in children as young as 1 year old, opening a new window to delay type 1 diabetes progression in the youngest patients.

All-in-One Insulin Pump + CGM by PharmaSens Clears Feasibility Study

News

Apr 14, 2026

All-in-One Insulin Pump + CGM by PharmaSens Clears Feasibility Study

Niia Essential demonstrated proof of concept, strong performance and accuracy, and zero insulin delivery failures in its first clinical study.

Dexcom

Mar 17, 2026

Dexcom Highlights CGM Advances and Product Roadmap at ATTD 2026

During the conference, Dexcom showcased upcoming device updates, new platform features, and future innovations designed to expand and enhance its CGM ecosystem.

Research

Mar 16, 2026

Inside Today's T1D Cure Research - Islet Cell Act & Eledon Trial Explained

A bill stalled in Congress and a promising clinical trial may together be the most important developments in type 1 diabetes treatment right now.

Promising Results for Omnipod’s Type 2 Fully Closed-Loop Algorithm

News

Mar 12, 2026

Promising Results for Omnipod’s Type 2 Fully Closed-Loop Algorithm

Results from the EVOLUTION 2 trial presented at ATTD showed 68% time in range using a fully closed-loop system—with no mealtime boluses and minimal time below range.

An Islet Cell Transplant Without Immunosuppression Shows Promise - We Spoke with Patient #1

Research

Feb 23, 2026

An Islet Cell Transplant Without Immunosuppression Shows Promise - We Spoke with Patient #1

Encapsulated neonatal pig islet cells, implanted without immunosuppression in the OPF-310 trial, cut a type 1 diabetes patient’s insulin needs in half at six months, with further maturation expected.

Research

Feb 17, 2026

Inside the FDA: Diabetes Tech Reviews, Recalls & Recent Politics

We spoke with an FDA-insider about how the organization regulates diabetes tech and how recent political events have shaken up the agency.

Afrezza Launches Trial to Bring Inhaled Insulin to Children With Type 1 Diabetes

News

Feb 12, 2026

Afrezza Launches Trial to Bring Inhaled Insulin to Children With Type 1 Diabetes

MannKind’s INHALE‐1ST trial is testing an inhaled insulin, as a needle‐free option for children with type 1 diabetes with an expected FDA decision by May 29, 2026.

Research

Nov 10, 2025

We Spoke with Breakthrough T1D’s CEO About its Mission to Cure Type 1 Diabetes

We interviewed the CEO of Breakthrough T1D about how the organization reshaped diabetes tech over the years, and its latest endeavors aimed at speeding cell therapy research to cure type 1 diabetes.

Novo Nordisk Shuts Down Cell Therapy Unit—What the Community Is Saying

News

Oct 15, 2025

Novo Nordisk Shuts Down Cell Therapy Unit—What the Community Is Saying

The move to end research into a potential type 1 diabetes cure has left many people with diabetes frustrated, reflective, and still holding on to hope.

The Future of Insulin: New Treatments & Innovations In The Works

Research

Sep 24, 2025

The Future of Insulin: New Treatments & Innovations In The Works

We dive into the history of insulin and the breakthroughs on the horizon—from smart insulin and oral treatments to weekly long-acting shots.

Research

Aug 11, 2025

T1Ds Are Using GLP-1s: The Latest Research & The Road To Coverage

Medications like Ozempic, Wegovy, and Mounjaro are showing promising results for people with type 1 diabetes — but they’re still not approved for this use.

Future Tech

May 19, 2025

This Implantable CBGM Will Measure Glucose Directly From The Blood

Glucotrack is working on a 3-year CGM implant that measures glucose directly from the blood.

Could SAB Bio's SAB-142 Therapy Stop Type 1 Diabetes?

Research

Apr 14, 2025

Could SAB Bio's SAB-142 Therapy Stop Type 1 Diabetes?

We spoke with SAB Bio about its innovative human-derived thymoglobulin therapy and its potential to delay or prevent type 1 diabetes.

Research

Mar 5, 2025

Sernova’s Search for a Diabetes Cure

Sernova’s groundbreaking cell pouch technology is on a quest for a future not just without type 1 diabetes, but also without the need for immunosuppressants. I asked them everything in my latest episode!

Research

Feb 28, 2025

The Case for a Type 1 Diabetes Cure

While many are skeptical there will ever be a cure, the amount of research and innovation in the works suggest otherwise

Research

Nov 5, 2024

CGMs Lower Hospitalizations for T2D Patients - New Research Shows

A recent study could alter the standard of diabetes care and access to CGMs

Diagnosed With Type 1.5 Diabetes — A LADA Diagnosis Story

Research

Jul 8, 2024

Diagnosed With Type 1.5 Diabetes — A LADA Diagnosis Story

Many adults diagnosed later in life may actually have LADA or type 1.5 diabetes — here’s how it works, how it differs, and a story navigating diagnosis.

The Future of Insulin: Innovations That Could Transform Diabetes Care

Future Tech

Dec 11, 2023

The Future of Insulin: Innovations That Could Transform Diabetes Care

Exploring inhaled options, smart pills, ultra-rapid formulations, and the breakthroughs reshaping insulin therapy.

Choosing the Right Infusion Set For You - All the Sets Compared

Future Tech

Oct 16, 2023

Choosing the Right Infusion Set For You - All the Sets Compared

I spoke with a leading Diabetes Educator about every infusion set - steel vs. flexible cannulas, angled vs. 90° insertions, site placement, and how each option fits each lifestyle.

Future Diabetes Tech: Where Innovation Is Headed Next

Future Tech

Sep 25, 2023

Future Diabetes Tech: Where Innovation Is Headed Next

Exploring the breakthroughs shaping tomorrow’s diabetes care—from implantable CGMs to bi-hormonal pumps and beyond

Research

Insulet Begins Pivotal Study of Fully Closed-Loop Omnipod for Type 2

FDA Expands Tzield to Children Age 1+ to Delay Type 1 Diabetes

All-in-One Insulin Pump + CGM by PharmaSens Clears Feasibility Study

Dexcom Highlights CGM Advances and Product Roadmap at ATTD 2026

Inside Today's T1D Cure Research - Islet Cell Act & Eledon Trial Explained

Promising Results for Omnipod’s Type 2 Fully Closed-Loop Algorithm

An Islet Cell Transplant Without Immunosuppression Shows Promise - We Spoke with Patient #1

Inside the FDA: Diabetes Tech Reviews, Recalls & Recent Politics

Afrezza Launches Trial to Bring Inhaled Insulin to Children With Type 1 Diabetes

We Spoke with Breakthrough T1D’s CEO About its Mission to Cure Type 1 Diabetes

Novo Nordisk Shuts Down Cell Therapy Unit—What the Community Is Saying

The Future of Insulin: New Treatments & Innovations In The Works

T1Ds Are Using GLP-1s: The Latest Research & The Road To Coverage

This Implantable CBGM Will Measure Glucose Directly From The Blood

Could SAB Bio's SAB-142 Therapy Stop Type 1 Diabetes?

Sernova’s Search for a Diabetes Cure

The Case for a Type 1 Diabetes Cure

CGMs Lower Hospitalizations for T2D Patients - New Research Shows

Diagnosed With Type 1.5 Diabetes — A LADA Diagnosis Story

The Future of Insulin: Innovations That Could Transform Diabetes Care

Choosing the Right Infusion Set For You - All the Sets Compared

Future Diabetes Tech: Where Innovation Is Headed Next

Diabetech